COVID-19 pandemicDRUGSMEDICAL careGENETIC polymorphismsEPIDEMIOLOGYCoronavirus disease 2019 pandemic is one of the most difficult challenges for modern medicine and health care. Since the beginning of its outbreak in different regions of the world, researchers have noticed differences ...
SR:We have come a long way since March 2020, but there's a lot we have to learn about COVID itself and long COVID. One article I refer patients to, published inCell, identified four factors that correlate with greater risk of long COVID—type 2 diabetes, prior infection with Epstein-B...
So far we haven't found any specific test to explain post COVID symptoms. This has confirmed our view that in most patients, long COVID symptoms are probably related to a complex interaction of physical and psychological processes that have arisen following the sudden inflammation caused by the ...
people with cardiovascular disease (CVD) were more than twice as likely to contract severe forms of COVID-19. In the last six months, death rates from COVID-19 have dropped significantly, but CVD remains a major predictor of poor outcome. What have we learned about heart disease...
risk of infection. In addition, many people are worried about new technologies that have not been used at large scale and for a long time in humans. Many assumed that mRNA vaccines were tested for the first time in humans for COVID-19 which is of course not correct since several trials ...
However, we must also accept that we are human, and the psychological impact of COVID on staff well-being must not be underestimated. It is OK not to be OK. Third, we are a powerful voice. The saying "if you do not have a seat at the table bring your own chair" resonates power...
COVID-19 could potentially have long-term impacts for CPS in many ways, depending on how the virus has affected a particular country; the country's overall response, including lockdowns, school closures, and travel restrictions; the state of a country's economy pre-COVID 19 and the nature...
doi: 10.7150/ijbs.45134 COVID-19: what has been learned and to be learned about the novel coronavirus disease Ye Yi, Philip N.P. Lagniton, Sen Ye, Enqin Li and Ren-He Xu Institute of Translational Medicine, and Centre of Reproduction, Development and Aging, Faculty of Health ...
Although the data are still limited and we have much to learn in this ongoing pandemic, we have enough evidence at this point to recommend that the ventilatory management of patients with COVID-19 ARDS should be similar to other causes of ARDS, tailored to the specific patient. References ...
KELLY: And next month the Biden administration plans to disband its COVID response team. CONSIDER THIS - for all the loss we have experienced during the COVID-19 pandemic, what have we learned from it? Well, one group set out to answer that question. We hear from the director of the ...